| Literature DB >> 33990496 |
Simon M Graham1,2,3, Sithombo Maqungo3,4, Maritz Laubscher3,4, Nando Ferreira5, Michael Held3,4, William J Harrison1,6, A Hamish Simpson7, Peter MacPherson8,9,10, David G Lalloo8,10.
Abstract
BACKGROUND: HIV reduces bone mineral density, mineralization, and turnover and may impair fracture healing.Entities:
Mesh:
Year: 2021 PMID: 33990496 PMCID: PMC8263144 DOI: 10.1097/QAI.0000000000002720
Source DB: PubMed Journal: J Acquir Immune Defic Syndr ISSN: 1525-4135 Impact factor: 3.771
FIGURE 1.Flow diagram of study population recruitment.
Baseline Characteristics of Study Participants, Stratified by HIV Status
| Characteristics | Study Cohort | HIV-Negative | HIV-Positive | |
| Sex, n (%) | ||||
| Men | 313 (78.3) | 262 (80.6) | 51 (68.0) | 0.030 |
| Women | 87 (21.7) | 63 (19.4) | 24 (32.0) | |
| Age, yrs: median (IQR) | 32.36 (18–71) | 31 (18–71) | 35 (19–58) | 0.080 |
| BMI, kg/m2: median (IQR) | 23.02 (15.54–51.19) | 22.9 (15.72–47.5) | 23.31 (15.55–51.2) | 0.720 |
| Fracture site, | ||||
| Tibia | 215 (48.6) | 171 (48.2) | 44 (50.6) | 0.460 |
| Femur | 227 (51.4) | 184 (51.8) | 43 (49.4) | |
| Open fracture, | ||||
| Yes | 161 (36.4) | 139 (39.2) | 22 (25.3) | 0.059 |
| No | 281 (63.6) | 216 (60.8) | 65 (74.7) | |
| No. of IM nailings performed per participant, n (%) | ||||
| 1 nail | 361 (90.3) | 296 (91.1) | 65 (86.7) | 0.340 |
| 2 nails | 37 (9.3) | 28 (8.6) | 9 (12.0) | |
| 3 nails | 1 (0.2) | 1 (0.3) | 0 | |
| 4 nails | 1 (0.2) | 0 | 1 (1.3) | |
| Drinks any alcohol, n (%) | ||||
| Yes | 223 (55.8) | 181 (55.7) | 42 (56.0) | 0.940 |
| No | 177 (44.2) | 144 (44.3) | 33 (44.0) | |
| Smoking status, n (%) | ||||
| Nonsmoker | 175 (43.8) | 134 (41.2) | 41 (54.7) | 0.050 |
| Smoker | 225 (56.2) | 191 (58.8) | 34 (45.3) | |
| Transfer from district hospital, n (%) | ||||
| Yes | 98 (24.5) | 74 (22.8) | 24 (32.0) | |
| No | 302 (75.5) | 251 (77.2) | 51 (68.0) | 0.100 |
| Time taken to arrive at treating hospital, hrs: median (IQR) | 9 (4–24) | 10 (4–24) | 12 (6–18) | 0.840 |
| Patient-reported outcome measure (PROM) | ||||
| DRI preoperatively, median (IQR) | 0 (0–34.3) | 0 (0–28) | 0 (0–34.3) | 0.090 |
N = 442 for study cohort, 355 HIV-negative, 87 HIV-positive.
BMI, body mass index; DRI, disability rating index.
Baseline Characteristics of HIV-Positive Participants
| HIV Status (N = 400) | |
| HIV-positive | 75 (18.8) |
| HIV-negative | 325 (81.2) |
Participants with a previous diagnosis of HIV before admission.
3TC, lamivudine; ; EFV, efavirenz; FTC, emtricitabine; LPV/r, lopinavir/ritonavir; TDF, tenofovir; ZDV, zidovudine.
Associations Between HIV Status and Fracture Delay or Nonunion
| HIV-Positive (N = 83), n (%) | HIV-Negative (N = 312), n (%) | Univariable Odds Ratio (95% CI) | Multivariable Odds Ratio (95% CI) | |
| Delayed union at 6 mo | 12 (14.5) | 57 (18.3) | 0.76 (0.369 to 1.44) | 1.06 (0.50 to 2.22) |
| Nonunion at 9 mo | 1 (1.2) | 22 (7.1) | 0.16 (0.01 to 0.78) | 0.17 (0.01 to 0.92) |
Adjusted for age, sex, smoking status, open fracture status, DSI, vitamin D level, and fracture site.
Adjusted for age, sex, smoking status, open fracture status, hemoglobin level, and vitamin D level.
Outcomes of Infection, Stratified According to HIV Status
| HIV-Positive (N = 83), n (%) | HIV-Negative (N = 312), n (%) | |
| DSI, n (%) | 7 (8.4) | 14 (4.5) |
| Superficial surgical site infection, n (%) | 1 (1.2) | 5 (1.6) |
| Late infection, n (%) | 5 (6.0) | 2 (0.6) |